ZVIAZevia PBC

NYSE zevia.com


$ 0.89 $ 0.02 (2.29 %)    

Friday, 10-May-2024 10:54:01 EDT
QQQ $ 441.34 $ -1.58 (-0.36 %)
DIA $ 394.85 $ -0.42 (-0.11 %)
SPY $ 520.52 $ -1.00 (-0.19 %)
TLT $ 90.08 $ -0.23 (-0.25 %)
GLD $ 218.25 $ -1.53 (-0.7 %)
$ 0.8701
$ 0.85
$ 0.00 x 0
$ 0.00 x 0
$ 0.85 - $ 0.89
$ 0.78 - $ 4.80
197,505
na
48.63M
$ 1.75
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 03-06-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-10-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-11-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-13-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 wells-fargo-maintains-equal-weight-on-zevia-lowers-price-target-to-1

Wells Fargo analyst Chris Carey maintains Zevia (NYSE:ZVIA) with a Equal-Weight and lowers the price target from $1.25 to $1.

 telsey-advisory-group-maintains-market-perform-on-zevia-lowers-price-target-to-2

Telsey Advisory Group analyst Dana Telsey maintains Zevia (NYSE:ZVIA) with a Market Perform and lowers the price target from...

 goldman-sachs-maintains-neutral-on-zevia-lowers-price-target-to-125

Goldman Sachs analyst Bonnie Herzog maintains Zevia (NYSE:ZVIA) with a Neutral and lowers the price target from $3 to $1.25.

 zevia-q1-2024-gaap-eps-010-inline-sales-38799m-miss-39428m-estimate

Zevia (NYSE:ZVIA) reported quarterly losses of $(0.10) per share which met the analyst consensus estimate. This is a 150 percen...

 morgan-stanley-maintains-equal-weight-on-zevia-lowers-price-target-to-2

Morgan Stanley analyst Dara Mohsenian maintains Zevia (NYSE:ZVIA) with a Equal-Weight and lowers the price target from $3 to...

 zevia-q4-2023-gaap-eps-014-inline-sales-3779m-beat-3735m-estimate

Zevia (NYSE:ZVIA) reported quarterly losses of $(0.14) per share which met the analyst consensus estimate. The company reporte...

 earnings-scheduled-for-february-27-2024

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on rev...

 telsey-advisory-group-reiterates-market-perform-on-zevia-maintains-4-price-target

Telsey Advisory Group analyst Dana Telsey reiterates Zevia (NYSE:ZVIA) with a Market Perform and maintains $4 price target.

 zevia-taps-girish-satya-as-cfo-effective-february-21-taking-over-from-interim-finance-chief-florence-neubauer-who-will-continue-as-senior-vice-president-finance-and-business-transformation

Zevia PBC ("Zevia" or the "Company") (NYSE:ZVIA), the company disrupting the liquid refreshment beverage indust...

 morgan-stanley-maintains-equal-weight-on-zevia-lowers-price-target-to-3

Morgan Stanley analyst Dara Mohsenian maintains Zevia (NYSE:ZVIA) with a Equal-Weight and lowers the price target from $3.25...

 zevia-q3-eps-016-inline-sales-4309m-beat-3957m-estimate

Zevia (NYSE:ZVIA) reported quarterly losses of $(0.16) per share which met the analyst consensus estimate. This is unchanged fr...

 earnings-scheduled-for-november-7-2023

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.

 stocks-that-hit-52-week-lows-on-tuesday

  On Tuesday, 647 companies set new 52-week lows.

 telsey-advisory-group-reiterates-market-perform-on-zevia-maintains-4-price-target

Telsey Advisory Group analyst Dana Telsey reiterates Zevia (NYSE:ZVIA) with a Market Perform and maintains $4 price target.

 where-zevia-stands-with-analysts
Where Zevia Stands With Analysts
08/09/2023 21:00:23

 morgan-stanley-maintains-equal-weight-on-zevia-lowers-price-target-to-325

Morgan Stanley analyst Dara Mohsenian maintains Zevia (NYSE:ZVIA) with a Equal-Weight and lowers the price target from $3.5 ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION